262 related articles for article (PubMed ID: 30334617)
1. Ribonucleoprotein Transfection for CRISPR/Cas9-Mediated Gene Knockout in Primary T Cells.
Oh SA; Seki A; Rutz S
Curr Protoc Immunol; 2019 Feb; 124(1):e69. PubMed ID: 30334617
[TBL] [Abstract][Full Text] [Related]
2. Optimized RNP transfection for highly efficient CRISPR/Cas9-mediated gene knockout in primary T cells.
Seki A; Rutz S
J Exp Med; 2018 Mar; 215(3):985-997. PubMed ID: 29436394
[TBL] [Abstract][Full Text] [Related]
3. Plasmid- or Ribonucleoprotein-Mediated CRISPR/Cas Gene Editing in Primary Murine T Cells.
Dölz M; Marone R; Jeker LT
Methods Mol Biol; 2021; 2285():255-264. PubMed ID: 33928558
[TBL] [Abstract][Full Text] [Related]
4. Efficient Multi-Allelic Genome Editing of Primary Cell Cultures via CRISPR-Cas9 Ribonucleoprotein Nucleofection.
Hoellerbauer P; Kufeld M; Paddison PJ
Curr Protoc Stem Cell Biol; 2020 Sep; 54(1):e126. PubMed ID: 32833346
[TBL] [Abstract][Full Text] [Related]
5. Editing the immune system in vivo in mice using CRISPR/Cas9 ribonucleoprotein (RNP)-mediated gene editing of transplanted hematopoietic stem cells.
Wang R; Graham S; Gao L; Tam J; Levesque MC
Methods; 2021 Oct; 194():30-36. PubMed ID: 33422676
[TBL] [Abstract][Full Text] [Related]
6. Direct Cytosolic Delivery of CRISPR/Cas9-Ribonucleoprotein for Efficient Gene Editing.
Mout R; Ray M; Yesilbag Tonga G; Lee YW; Tay T; Sasaki K; Rotello VM
ACS Nano; 2017 Mar; 11(3):2452-2458. PubMed ID: 28129503
[TBL] [Abstract][Full Text] [Related]
7. A Cas9 Ribonucleoprotein Platform for Functional Genetic Studies of HIV-Host Interactions in Primary Human T Cells.
Hultquist JF; Schumann K; Woo JM; Manganaro L; McGregor MJ; Doudna J; Simon V; Krogan NJ; Marson A
Cell Rep; 2016 Oct; 17(5):1438-1452. PubMed ID: 27783955
[TBL] [Abstract][Full Text] [Related]
8. Plasmid-Based Donor Templates for Nonviral CRISPR/Cas9-Mediated Gene Knock-In in Human T Cells.
Senger K; Akhmetzyanova I; Haley B; Rutz S; Oh SA
Curr Protoc; 2022 Sep; 2(9):e538. PubMed ID: 36130036
[TBL] [Abstract][Full Text] [Related]
9. Highly Efficient Gene Disruption of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9.
Brunetti L; Gundry MC; Kitano A; Nakada D; Goodell MA
J Vis Exp; 2018 Apr; (134):. PubMed ID: 29708546
[TBL] [Abstract][Full Text] [Related]
10. Genome editing in potato via CRISPR-Cas9 ribonucleoprotein delivery.
Andersson M; Turesson H; Olsson N; Fält AS; Ohlsson P; Gonzalez MN; Samuelsson M; Hofvander P
Physiol Plant; 2018 Dec; 164(4):378-384. PubMed ID: 29572864
[TBL] [Abstract][Full Text] [Related]
11. Genome Editing in Chlamydomonas reinhardtii Using Cas9-gRNA Ribonucleoprotein Complex: A Step-by-Step Guide.
Dhokane D; Kancharla N; Savarimuthu A; Bhadra B; Bandyopadhyay A; Dasgupta S
Methods Mol Biol; 2023; 2653():207-217. PubMed ID: 36995629
[TBL] [Abstract][Full Text] [Related]
12. Cas9 Ribonucleoprotein Complex Delivery: Methods and Applications for Neuroinflammation.
Campbell LA; Richie CT; Maggirwar NS; Harvey BK
J Neuroimmune Pharmacol; 2019 Dec; 14(4):565-577. PubMed ID: 31172397
[TBL] [Abstract][Full Text] [Related]
13. Rapid and Efficient Gene Editing for Direct Transplantation of Naive Murine Cas9
Majumder S; Jugovic I; Saul D; Bell L; Hundhausen N; Seal R; Beilhack A; Rosenwald A; Mougiakakos D; Berberich-Siebelt F
Front Immunol; 2021; 12():683631. PubMed ID: 34367143
[TBL] [Abstract][Full Text] [Related]
14. Biomimetic Mineralization-Based CRISPR/Cas9 Ribonucleoprotein Nanoparticles for Gene Editing.
Li S; Song Z; Liu C; Chen XL; Han H
ACS Appl Mater Interfaces; 2019 Dec; 11(51):47762-47770. PubMed ID: 31773942
[TBL] [Abstract][Full Text] [Related]
15. Efficient DNA-free genome editing of bread wheat using CRISPR/Cas9 ribonucleoprotein complexes.
Liang Z; Chen K; Li T; Zhang Y; Wang Y; Zhao Q; Liu J; Zhang H; Liu C; Ran Y; Gao C
Nat Commun; 2017 Jan; 8():14261. PubMed ID: 28098143
[TBL] [Abstract][Full Text] [Related]
16. Lipofection-Based Delivery of CRISPR/Cas9 Ribonucleoprotein for Gene Editing in Male Germline Stem Cells.
Obermeier M; Rogiers V; Vanhaecke T; Baert Y
Methods Mol Biol; 2024; 2770():123-134. PubMed ID: 38351451
[TBL] [Abstract][Full Text] [Related]
17. Generation of tumor antigen-specific murine CD8+ T cells with enhanced anti-tumor activity via highly efficient CRISPR/Cas9 genome editing.
Ouchi Y; Patil A; Tamura Y; Nishimasu H; Negishi A; Paul SK; Takemura N; Satoh T; Kimura Y; Kurachi M; Nureki O; Nakai K; Kiyono H; Uematsu S
Int Immunol; 2018 Apr; 30(4):141-154. PubMed ID: 29617862
[TBL] [Abstract][Full Text] [Related]
18. Ex Vivo Expansion and CRISPR-Cas9 Genome Editing of Primary Human Natural Killer Cells.
Huang RS; Lai MC; Lin S
Curr Protoc; 2021 Sep; 1(9):e246. PubMed ID: 34529358
[TBL] [Abstract][Full Text] [Related]
19. Efficient CRISPR/Cas9 Gene Editing in Uncultured Naive Mouse T Cells for In Vivo Studies.
Nüssing S; House IG; Kearney CJ; Chen AXY; Vervoort SJ; Beavis PA; Oliaro J; Johnstone RW; Trapani JA; Parish IA
J Immunol; 2020 Apr; 204(8):2308-2315. PubMed ID: 32152070
[TBL] [Abstract][Full Text] [Related]
20. Efficient Editing of the CXCR4 Locus Using Cas9 Ribonucleoprotein Complexes Stabilized with Polyglutamic Acid.
Golubev DS; Komkov DS; Shepelev MV; Mazurov DV; Kruglova NA
Dokl Biol Sci; 2023 Dec; 513(Suppl 1):S28-S32. PubMed ID: 38190037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
